Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Fastenal, Exela Technologies, Spectrum Pharmaceuticals and more - PRE-MARKET

Proactive takes a look at pre-market trade in New York on Wednesday

US benchmarks are seen starting lower on Wednesday after yesterday's rally, with goods distributor and manufacturer Fastenal Co (NASDAQ:FAST) seeing shares down 4.15% ahead of the bell at US$52.16 each.

It comes as the manufacturer of fasteners and tools reported first-quarter profit and sales that increased only in line with expectations, which disappointed.

Fastenal matches profit and sales expectations, shares fall

— FDR Investment Group (@FDRInvestments) 11 April 2018

Spectrum Pharmaceuticals Inc (NASDAQ: SPPI) added nearly 6% to US$22 after hours as the company unveiled positive data from its lung cancer drug.

In other pre-market news, Exela Technologies Inc (NASDAQ:XELA) shed 5.69% to US$5.30 after it announced a 1.05mln stock offering on behalf of Ex-Sigma 2.

Elsewhere, Analogic Corporation (NASDAQ:ALOG) saw its shares plunge over 12% after hours to US$84.15 each as the multinational agreed to be bought by Altaris Capital Affiliate for US$84 per share.

Facebook Inc (NASDAQ:FB.), the social behemoth, shed 0.71% to US$163.87 after the bell as Mark Zuckerberg faced hours of questions by US senators.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK